Treatment of post-thalamic hemorrhage hydrocephalus: ventriculoperitoneal shunt or endoscopic third ventriculostomy? A retrospective observational study.
Humans
Hydrocephalus
/ surgery
Ventriculoperitoneal Shunt
/ methods
Male
Ventriculostomy
/ methods
Female
Retrospective Studies
Middle Aged
Third Ventricle
/ surgery
Aged
Adult
Treatment Outcome
Neuroendoscopy
/ methods
Cerebral Hemorrhage
/ surgery
Thalamus
/ surgery
Postoperative Complications
/ epidemiology
Endoscopic third ventriculostomy
External ventricular drains
Hydrocephalus
Thalamic hemorrhage
Ventriculoperitoneal shunt
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
28 Sep 2024
28 Sep 2024
Historique:
received:
04
01
2024
accepted:
24
09
2024
medline:
29
9
2024
pubmed:
29
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
The aim of this study was to compare the efficacy of ventriculoperitoneal shunt (VPS) and endoscopic third ventriculostomy (ETV) for the treatment of hydrocephalus after thalamic hemorrhage (TH) where external ventricular drainage (EVD) could not be removed after hematoma absorption, and to provide a theoretical basis for the clinical treatment of hydrocephalus after TH. The clinical data of patients with hydrocephalus after TH whose EVD could not be removed after hematoma absorption were retrospectively analyzed. According to the patients' surgical methods, the patients were divided into the VPS group and ETV group. The operative time, length of hospital stay, complications, and reoperation rates of the two groups were compared. There was no statistically significant difference in intraoperative bleeding, length of hospital stay between the two groups. The EVD tubes were successfully removed in all patients after surgery. There were 4 (9.5%) complications in the ETV group and 3 (6.7%) complications in the VPS group, with no statistically significant difference in postoperative complications between the two groups. During the 1-year follow-up, 7 patients (16.7%) in the ETV group and 3 patients (6.7%) in the VPS group required reoperation. In the subgroup analysis of TH combined with fourth ventricular hemorrhage, 6 patients (14.3%) in the ETV group and 1 patient (2.2%) in the VPS group required reoperation, and the difference between the two groups was statistically significant. ETV had good efficacy in treating hydrocephalus caused by TH and TH that broke into the lateral ventricle and the third ventricle. However, if hydrocephalus was caused by TH with the fourth ventricular hematoma, VPS was a better surgical method because the recurrence rate of hydrocephalus in ETV was higher than that in VPS. Therefore, the choice of surgical method should be based on the patient's clinical features and hematoma location.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of this study was to compare the efficacy of ventriculoperitoneal shunt (VPS) and endoscopic third ventriculostomy (ETV) for the treatment of hydrocephalus after thalamic hemorrhage (TH) where external ventricular drainage (EVD) could not be removed after hematoma absorption, and to provide a theoretical basis for the clinical treatment of hydrocephalus after TH.
METHODS
METHODS
The clinical data of patients with hydrocephalus after TH whose EVD could not be removed after hematoma absorption were retrospectively analyzed. According to the patients' surgical methods, the patients were divided into the VPS group and ETV group. The operative time, length of hospital stay, complications, and reoperation rates of the two groups were compared.
RESULTS
RESULTS
There was no statistically significant difference in intraoperative bleeding, length of hospital stay between the two groups. The EVD tubes were successfully removed in all patients after surgery. There were 4 (9.5%) complications in the ETV group and 3 (6.7%) complications in the VPS group, with no statistically significant difference in postoperative complications between the two groups. During the 1-year follow-up, 7 patients (16.7%) in the ETV group and 3 patients (6.7%) in the VPS group required reoperation. In the subgroup analysis of TH combined with fourth ventricular hemorrhage, 6 patients (14.3%) in the ETV group and 1 patient (2.2%) in the VPS group required reoperation, and the difference between the two groups was statistically significant.
CONCLUSIONS
CONCLUSIONS
ETV had good efficacy in treating hydrocephalus caused by TH and TH that broke into the lateral ventricle and the third ventricle. However, if hydrocephalus was caused by TH with the fourth ventricular hematoma, VPS was a better surgical method because the recurrence rate of hydrocephalus in ETV was higher than that in VPS. Therefore, the choice of surgical method should be based on the patient's clinical features and hematoma location.
Identifiants
pubmed: 39342184
doi: 10.1186/s12883-024-03880-0
pii: 10.1186/s12883-024-03880-0
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
365Informations de copyright
© 2024. The Author(s).
Références
Nam TM, Jang JH, Kim SH, Kim KH, Kim YZ. Comparative analysis of the patients with spontaneous thalamic hemorrhage with concurrent intraventricular hemorrhage and those without intraventricular hemorrhage. J Korean Med Sci. 2021;36(1):e4.
doi: 10.3346/jkms.2021.36.e4
pubmed: 33398941
Lee SH, Park KJ, Kang SH, Jung YG, Park JY, Park DH. Prognostic factors of clinical outcomes in patients with spontaneous thalamic hemorrhage. Med Sci Monit. 2015;21:2638–46.
doi: 10.12659/MSM.894132
pubmed: 26343784
pmcid: 4566943
Neisewander BL, Hu K, Tan Z, Zakrzewski J, Kheirkhah P, Kumar P, Shah M, Cotanche D, Shah K, Esfahani DR, Mehta AI. Location of thalamic hemorrhage impacts prognosis. World Neurosurg. 2018;116:e525–33.
doi: 10.1016/j.wneu.2018.05.026
pubmed: 29772365
Li M, Mu FQ, Han Q, Su DP, Guo ZZ, Chen T. Intraventricular fibrinolytic for the treatment of intraventricular hemorrhage: a network meta-analysis. Brain Inj. 2020;34(7):864–70.
doi: 10.1080/02699052.2020.1764103
pubmed: 32447964
Vogel TW, Bahuleyan B, Robinson S, Cohen AR. The role of endoscopic third ventriculostomy in the treatment of hydrocephalus. J Neurosurg Pediatr. 2013;12(1):54–61.
doi: 10.3171/2013.4.PEDS12481
pubmed: 23682819
Fukuhara T, Shimizu T, Namba Y. Limited efficacy of endoscopic third ventriculostomy for hydrocephalus following aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2009;49(10):449–55.
doi: 10.2176/nmc.49.449
pubmed: 19855140
Feng HL, Huang GF, Tan HB, Pu H, Cheng Y, Liu WD, Zhao DD. Endoscopic third ventriculostomy in the management of communicating hydrocephalus: a preliminary study. J Neurosurg. 2008;109(5):923–30.
doi: 10.3171/JNS/2008/109/11/0923
Rangel-Castilla L, Barber S, Zhang YJ. The role of endoscopic third ventriculostomy in the treatment of communicating hydrocephalus. World Neurosurg. 2012;77(3–4):555–60.
doi: 10.1016/j.wneu.2011.06.038
pubmed: 22120350
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. Strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–8.
doi: 10.1136/bmj.39335.541782.AD
Hinson HE, Hanley DF, Ziai WC. Management of intraventricular hemorrhage. Curr Neurol Neurosci Rep. 2010;10(2):73–82.
doi: 10.1007/s11910-010-0086-6
pubmed: 20425231
pmcid: 3138489
Zacharia BE, Vaughan KA, Hickman ZL, Bruce SS, Carpenter AM, Petersen NH, Deiner S, Badjatia N, Connolly ES. Predictors of long-term shuntdependent hydrocephalus in patients with intracerebral hemorrhage requiring emergency cerebrospinal fluid diversion. Neurosurg Focus. 2012;32(4):E5.
doi: 10.3171/2012.2.FOCUS11372
pubmed: 22463115
Kuo LT, Lu HY, Tsai JC, Tu YK. Prediction of shunt dependency after intracerebral hemorrhage and intraventricular hemorrhage. Neurocrit Care. 2018;29(2):233–40.
doi: 10.1007/s12028-018-0532-x
pubmed: 29790116
Wright P, Horowitz DR, Tuhrim S, Bederson JB. Clinical improvement related to thrombolysis of third ventricular blood clot in a patient with thalamic hemorrhage. J Stroke Cerebrovasc Dis. 2001;10(1):23–6.
doi: 10.1053/jscd.2001.20975
pubmed: 17903795
Greenberg M. Handbook of neurosurgery. 8th. New York: Thieme Medical; 2016.
doi: 10.1055/b-006-149702
Riegel T, Hellwig D, Bauer BL, Mennel HD. Endoscopic anatomy of the third ventricle. Acta Neurochir Suppl. 1994;61:54–6.
pubmed: 7771225
Mehta NH, Greenberg ABW, Kahle KT. The efficacy of endoscopic third ventriculostomy for idiopathic normal pressure hydrocephalus. World Neurosurg. 2023;179:158–66.
doi: 10.1016/j.wneu.2023.08.071
pubmed: 37625638
Madsen PJ, Mallela AN, Hudgins ED, Storm PB, Heuer GG, Stein SC. The effect and evolution of patient selection on outcomes in endoscopic third ventriculostomy for hydrocephalus: a large-scale review of the literature. J Neurol Sci. 2018;385:185–91.
doi: 10.1016/j.jns.2017.12.025
pubmed: 29406903
Jallo GI, Kothbauer KF, Abbott IR. Endoscopic Third Ventriculostomy Neurosurg Focus. 2005;19(6):E11.
pubmed: 16398476
Moorthy RK, Rajshekhar V. Endoscopic third ventriculostomy for hydrocephalus: a review of indications, outcomes, and complications. Neurol India. 2011;59(6):848–54.
doi: 10.4103/0028-3886.91364
pubmed: 22234198
Hellwig D, Grotenhuis JA, Tirakotai W, Riegel T, Schulte DM, Bauer BL, Bertalanffy H. Endoscopic third ventriculostomy for obstructive hydrocephalus. Neurosurg Rev. 2005;28(1):1–34.
pubmed: 15570445
Zeineddine HA, Dono A, Kitagawa R, Savitz SI, Choi HA, Chang TR, Ballester LY, Esquenazi Y. Endoscopic third ventriculostomy for hydrocephalus secondary to extraventricular obstruction in thalamic hemorrhage: a case series. Oper Neurosurg (Hagerstown). 2020;19(4):384–92.
doi: 10.1093/ons/opaa094
pubmed: 32365205
Obaid S, Weil AG, Rahme R, Bojanowski MW. Endoscopic third ventriculostomy for obstructive hydrocephalus due to intraventricular hemorrhage. J Neurol Surg Cent Eur Neurosurg. 2015;76(2):99–111.
doi: 10.1055/s-0034-1382778
Bouramas D, Paidakakos N, Sotiriou F, Kouzounias K, Sklavounou M, Gekas N. Endoscopic third ventriculostomy in obstructive hydrocephalus: surgical technique and pitfalls. Acta Neurochir Suppl. 2012;113:135–9.
doi: 10.1007/978-3-7091-0923-6_27
pubmed: 22116439
Luther E, McCarthy D, Sedighim S, Niazi T. Endoscopic third ventriculostomy inpatient failure rates compared with shunting in post-hemorrhagic hydrocephalus of prematurity. Childs Nerv Syst. 2020;36(3):559–68.
doi: 10.1007/s00381-019-04465-w
pubmed: 31863148
Siomin V, Cinalli G, Grotenhuis A, Golash A, Oi S, Kothbauer K, Weiner H, Roth J, Beni-Adani L, Pierre-Kahn A, Takahashi Y, Mallucci C, Abbott R, Wisoff J, Constantini S. Endoscopic third ventriculostomy in patients with cerebrospinal fluid infection and/or hemorrhage. J Neurosurg. 2002;97(3):519–24.
doi: 10.3171/jns.2002.97.3.0519
pubmed: 12296633
Pinto FC, Saad F, Oliveira MF, Pereira RM, Miranda FL, Tornai JB, Lopes MI, Ribas ES, Valinetti EA, Teixeira MJ. Role of endoscopic third ventriculostomy and ventriculoperitoneal shunt in idiopathic normal pressure hydrocephalus: preliminary results of a randomized clinical trial. Neurosurgery. 2013;72(5):845–53.